
So-Young International SY
$ 2.99
0.51%
Annual report 2024
added 01-17-2026
So-Young International Accounts Payables 2011-2026 | SY
Accounts payable — are the obligations of an organization to other legal entities or individuals that arise in cases when the company has acquired goods or services on deferred payment terms, has not paid taxes and fees, has wage arrears to employees, or has received loans and other liabilities. Accounts payable arise when an organization has already received some benefit but has not yet paid for it.Main types of accounts payable
| Type of liability | Example |
|---|---|
| To suppliers and contractors | Goods received but not yet paid for |
| Taxes and fees | VAT, income tax, etc., not paid on time |
| Salaries | Employee wages not paid |
| To budgets | Insurance contributions to funds not paid |
| To founders | Founders provided borrowed funds |
| To banks | Overdue loan payments |
| Other | Fines, penalties, forfeits, customer prepayments, etc. |
Impact on the company's financial performance
- Liquidity and solvency
Accounts payable are part of short-term liabilities, so they affect liquidity ratios - Financial stability
The higher the share of borrowed funds (including accounts payable), the lower the company's level of independence - Capital turnover
Moderate accounts payable can positively affect working capital by allowing the company to use “free” financing from suppliers (payment deferrals) - Risks and reputation
Large and especially overdue accounts payable may indicate financial difficulties. This can deter investors, partners, and lenders, and at a critical level of debt and lack of resources to repay it, bankruptcy proceedings may be initiated
Quarterly Accounts Payables So-Young International
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 18.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in CNY currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 18.8 M | 18.8 M | 18.8 M |
Accounts Payables of other stocks in the Health information services industry
| Issuer | Accounts Payables | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Cerner Corporation
CERN
|
330 M | - | - | $ 27.9 B | ||
|
Computer Programs and Systems
CPSI
|
10.1 M | - | 4.4 % | $ 133 M | ||
|
Covetrus
CVET
|
442 M | - | - | $ 2.94 B | ||
|
Change Healthcare
CHNG
|
104 M | - | - | $ 9.03 B | ||
|
Accolade
ACCD
|
7.39 M | - | 0.29 % | $ 206 M | ||
|
Evolent Health
EVH
|
57.2 M | $ 3.91 | 1.69 % | $ 366 M | ||
|
Akerna Corp.
KERN
|
5.51 M | - | - | $ 161 M | ||
|
Schrödinger
SDGR
|
10.7 M | $ 17.34 | 0.06 % | $ 1.26 B | ||
|
Health Catalyst
HCAT
|
11.4 M | $ 2.28 | -3.6 % | $ 137 M | ||
|
HealthStream
HSTM
|
6.63 M | $ 21.2 | -1.28 % | $ 644 M | ||
|
iCAD
ICAD
|
1.11 M | - | - | $ 102 M | ||
|
Allscripts Healthcare Solutions
MDRX
|
16.8 M | - | -10.39 % | $ 886 M | ||
|
10x Genomics
TXG
|
15.7 M | $ 23.2 | 0.04 % | $ 2.72 B | ||
|
HealthEquity
HQY
|
12 M | $ 84.57 | -2.14 % | $ 7.24 B | ||
|
American Well Corporation
AMWL
|
5.02 M | $ 4.9 | -0.61 % | $ 73.5 M | ||
|
MTBC
MTBC
|
4.56 M | - | -0.58 % | $ 51.7 M | ||
|
1Life Healthcare
ONEM
|
18.7 M | - | - | $ 3.37 B | ||
|
GoodRx Holdings
GDRX
|
14.1 M | $ 2.59 | 0.74 % | $ 999 M | ||
|
OptimizeRx Corporation
OPRX
|
2.23 M | $ 11.77 | -1.59 % | $ 202 M | ||
|
Omnicell
OMCL
|
51.8 M | $ 50.54 | -1.52 % | $ 2.33 B | ||
|
Premier
PINC
|
19.6 M | - | - | $ 2.33 B | ||
|
Progyny
PGNY
|
95.1 M | $ 25.02 | 0.08 % | $ 2.15 B | ||
|
Phreesia
PHR
|
8.48 M | $ 15.9 | 0.63 % | $ 868 M | ||
|
R1 RCM
RCM
|
17.7 M | - | - | $ 3.81 B | ||
|
Zhongchao
ZCMD
|
535 K | $ 0.43 | -5.26 % | $ 2.24 M | ||
|
NantHealth
NH
|
10.4 M | - | -46.64 % | $ 10.4 M | ||
|
NextGen Healthcare
NXGN
|
11.4 M | - | - | $ 1.6 B | ||
|
Signify Health
SGFY
|
84.1 M | - | -0.02 % | $ 7.21 B | ||
|
Streamline Health Solutions
STRM
|
1.54 M | - | - | $ 21.4 M | ||
|
Teladoc Health
TDOC
|
33.1 M | $ 6.35 | -0.08 % | $ 1.08 B | ||
|
Tabula Rasa HealthCare
TRHC
|
19.5 M | - | - | $ 255 M | ||
|
Veeva Systems
VEEV
|
31.5 M | $ 223.5 | -0.79 % | $ 35.9 B | ||
|
SCWorx Corp.
WORX
|
600 K | $ 0.21 | 12.68 % | $ 306 K |